Kelnor 1/35

  • Contraception

Kelnor 1/35 Generic Name & Formulations

General Description

Ethynodiol diacetate 1mg, ethinyl estradiol 35mcg, 21 tabs; inert (7 tabs).

Pharmacological Class

Progestin + estrogen.

How Supplied



Kelnor 1/35 Indications


Oral contraception.

Kelnor 1/35 Dosage and Administration


1 tab daily for 28 days; repeat.


Not applicable.

Kelnor 1/35 Contraindications


Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Kelnor 1/35 Boxed Warnings

Not Applicable

Kelnor 1/35 Warnings/Precautions


Smokers over 35 years of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended.

Kelnor 1/35 Pharmacokinetics

See Literature

Kelnor 1/35 Interactions


Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Kelnor 1/35 Adverse Reactions

Adverse Reactions

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Kelnor 1/35 Clinical Trials

See Literature

Kelnor 1/35 Note

Not Applicable

Kelnor 1/35 Patient Counseling

See Literature